Correlation between conjunctival scraping cytology and other clinical dry eye metrics in determination of dry eye related inflammation
Abstract
Abstract
Background/Aim. New and improved definition of dry eye disease (DED) emphasized that hiperosmolarity and inflammation with initial tear film instability play etiological role. The aim of this study was to explore relation of some commonly used clinical tests to dry eye disease (DED) related inflammation measured by conjunctival scraping cytology. Methods. We examined 100 subjects, 80 of them having DED. We performed Schirmer without anesthesia (Schirmer I), Fluorescein Tear Break Up Time (FTBUT), Rose Bengal (RB), Lid Parallel Conjunctival Folds (LIPCOF), Tear Meniscus Height (TMH) and Tear Ferning (TF) and compared the values to scraping scores of tarsal conjunctiva. Results. FTBUT had the best sensitivity (93.6%). The highest specificity was found with RB (93.2%), but it was also high with Schirmer I, TF and FTBUT (respectively 89.8%, 84.5%, 78.0%). RB and FTBUT had the highest correlation with conjunctival scraping score (r = 0.707, p < 0.001; r = -0.507, p < 0.001). Conclusion. In our study, FTBUT, though often used in many combinations of the DED tests, showed a remarkably high sensitivity and specificity on its own, as well as good correlation with DED related inflammation detected with conjunctival scraping cytology.
References
REFERENCES
The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 75–92.
Baudouin C, Aragona P, Messmer EM, Tomlinson A, Calonge M, Boboridis KG, et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting. Ocul Surf 2013; 11(4): 246–58.
Aslan Bayhan S, Bayhan HA, Muhafız E, Bekdemir Ş, Gürdal CC. Effects of osmoprotective eye drops on tear osmolarity in contact lens wearers. Can J Ophthalmol 2015; 50(4): 283–9.
Leonardi A, Flamion B, Baudouin C. Keratitis in Dry Eye Disease and Topical Ciclosporin A. Ocul Immunol Inflamm 2017; 25(4): 577–86.
Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf 2017; 15(3): 276–83.
Versura P, Profazio V, Campos EC. Performance of tear osmo-larity compared to previous diagnostic tests for dry eye diseas-es. Curr Eye Res 2010; 35(7): 553–64.
Sambursky R, Davitt WF, Latkany R, Tauber S, Starr C, Friedberg M, et al. Sensitivity and specificity of a point-of-care matrix metalloproteinase 9 immunoassay for diagnosing inflammation related to dry eye. JAMA Ophthalmol 2013; 131(1): 24–8.
Messmer EM, von Lindenfels V, Garbe A, Kampik A. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Com-mercially Available Point-of-Care Immunoassay. Ophthalmol-ogy 2016; 123(11): 2300–8.
Versura P, Profazio V, Fresina M, Campos EC. A novel scraping cytology score system (SCSS) grades inflammation in dry eye patients. Curr Eye Res 2009; 34(5): 340–6.
Manthorpe R, Oxholm P, Prause JU, Schiødt M. The Copenhagen criteria for Sjögren's syndrome. Scand J Rheumatol Suppl 1986; 61: 19–21.
Höh H, Schirra F, Kienecker C, Ruprecht KW. Lid-parallel con-junctival folds are a sure diagnostic sign of dry eye. Der Oph-thalmologe 1995; 92(6): 802–8. (German)
Michel M, Sickenberger W, Pult H. The effectiveness of questionnaires in the determination of Contact Lens Induced Dry Eye. Ophthalmic Physiol Opt 2009; 29(5): 479–86.
Messmer EM. The pathophysiology, diagnosis, and treatment of dry eye disease. Dtsch Arztebl Int. 2015 Jan 30;112(5):71–81; quiz 82.
Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the Interna-tional Dry Eye WorkShop (2007). Ocul Surf 2007; 5(2): 108–52.
Evans KS, North RV, Purslow C. Tear ferning in contact lens wearers. Ophthalmic Physiol Opt 2009; 29(2): 199–204.
Amparo F, Dastjerdi MH, Okanobo A, Ferrari G, Smaga L, Ha-mrah P, et al. Topical interleukin 1 receptor antagonist for treatment of dry eye disease: A randomized clinical trial. JAMA Ophthalmol 2013; 131(6): 715–23.
Stevenson W, Chauhan SK, Dana R. Dry eye disease: An immune-mediated ocular surface disorder. Arch Ophthalmol 2012; 130(1): 90–100.
Stern ME, Schaumburg CS, Pflugfelder SC. Dry eye as a mucosal autoimmune disease. Int Rev Immunol 2013; 32(1): 19–41.
Calonge M, Enríquez--Salamanca A, Diebold Y, González-García MJ, Reinoso R, Herreras JM, et al. Dry eye disease as an inflam-matory disorder. Ocul Immunol Inflamm 2010; 18(4): 244–53.
Alves M, Reinach PS, Paula JS, Vellasco CA, Bachette L, Faustino J, et al. Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease. PLoS ONE 2014; 9(5): e97921.
Bartlett JD, Keith MS, Sudharshan L, Snedecor SJ. Associations between signs and symptoms of dry eye disease: A systematic review. Clin Ophthalmol 2015; 9: 1719–30.
Lewis R. New New View of Dry Eye Stresses Mechanisms Over Manifestations. Medscape 2017. Available from:
http://www.medscape.com/viewarticle/879675?nlid=114929_450&src=WNL _mdplsfeat_170516_mscpedit_opth&uac= 159098SY&spon=36&impID=1348993&faf=1#vp_2 [cited 2017 May 8].
Vehof J, Sillevis Smitt-Kamminga N, Nibourg SA, Hammond CJ. Predictors of Discordance between Symptoms and Signs in Dry Eye Disease. Ophthalmology 2017; 124(3): 280–6.